Help - Search - Members - Calendar
Full Version: Churg-Strauss-Syndrome
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Churg-Strauss-Syndrome
  1. Montelukast: churg-strauss syndrome: case report (0 replies)
  2. Epidemiology of primary systemic vasculitis in the australian capital territory and south-eastern new south wales (0 replies)
  3. Montelukast: churg-strauss syndrome: case report. (0 replies)
  4. Notice of retraction: increased expression of trail receptor 3 on eosinophils in churg-strauss syndrome (arthritis rheum 2007;56:662-73) (0 replies)
  5. Anca-negative glomerulonephritis associated with nonasthmatic churg-strauss syndrome (0 replies)
  6. [interdisciplinary point of contact between rheumatology and pneumology.] (0 replies)
  7. Repressed ileal artery aneurysms in churg-strauss syndrome following combination treatment with glucocorticoid and cyclophosphamide (0 replies)
  8. Montelukast associated with churg-strauss syndrome but not the cause (0 replies)
  9. Rhinologic symptoms and quality-of-life in patients with churg-strauss syndrome vasculitis (0 replies)
  10. A case of churg-strauss syndrome revealed by eosinophilic gastroenteritis (0 replies)
  11. [early-onset of churg-strauss syndrome.] (0 replies)
  12. [asthma] the leucotriene receptor antagonist montelukast and the risk of churg-strauss syndrome: a case-crossover study (0 replies)
  13. [case report] apparent response to anti-ige therapy in two patients with refractory "forme fruste" of churg-strauss syndrome (0 replies)
  14. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies. (0 replies)
  15. Churg-strauss syndrome associated with montelukast therapy (0 replies)
  16. Fluticasone propionate: churg-strauss syndrome: case report (0 replies)
  17. Fluticasone propionate: churg-strauss syndrome: case report. (0 replies)
  18. Churg–strauss syndrome with peripheral gangrene and severe renal failure (0 replies)
  19. [diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement.] (0 replies)
  20. [congestive cardiomyopathy and left intraventricular thrombus as a manifestation of churg-strauss syndrome.] (0 replies)
  21. Omalizumab and churg-strauss syndrome. (0 replies)
  22. Differences in regulatory t cells between churg-strauss syndrome and chronic eosinophilic pneumonia with asthma. (0 replies)
  23. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis (0 replies)
  24. Rituximab is effective in the treatment of refractory churg-strauss syndrome and is associated with diminished t-cell interleukin-5 production (0 replies)
  25. Churg-strauss syndrome associated with omalizumab. (0 replies)
  26. Aspirin tolerance and leukotriene biosynthesis in churg-strauss syndrome (0 replies)
  27. [extended reports] outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the european league against rheumatism systemic vasculitis task force (0 replies)
  28. Involvement of regulatory t cells in the pathogenesis of churg-strauss syndrome (1 reply)
  29. Leukotriene antagonists link to churg strauss syndrome (1 reply)
  30. Systematic review shows association between leukotriene antagonist use and churg strauss syndrome (1 reply)
  31. Classification of eosinophilic gastrointestinal diseases. (1 reply)
  32. Churg-strauss syndrome and revascularization of the hand: a case report. (1 reply)
  33. Subarachnoid haemorrhage as the first clinical manifestation of churg-strauss syndrome (1 reply)
  34. Leukotriene receptor antagonists and churg-strauss syndrome: an association with relevance to dermatopathology? (1 reply)
  35. Omalizumab: churg-strauss syndrome following corticosteroid withdrawal: case report. (1 reply)
  36. Omalizumab: churg-strauss syndrome following corticosteroid withdrawal: case report (1 reply)
  37. A case of churg-strauss syndrome with refractory otitis media. (1 reply)
  38. Magnetic resonance assessment and therapy monitoring of cardiac involvement in churg-strauss syndrome. (1 reply)
  39. Evaluation of a new algorithm in classification of systemic vasculitis (1 reply)
  40. Retraction of matsuyama et al. discoidin domain receptor 1 contributes to eosinophil survival in an nf-{kappa}b-dependent manner in churg-strauss syndrome (1 reply)
  41. Focused microarray analysis of peripheral mononuclear blood cells from churg-strauss syndrome patients (1 reply)
  42. Subarachnoid haemorrhage as the first clinical manifestation of churg-strauss syndrome (1 reply)
  43. Montelukast and risk of churg-strauss syndrome (0 replies)
  44. [monocular blindness as the first symptom of churg-strauss syndrome.] (0 replies)
  45. [hypereosinophilic asthma.] (0 replies)
  46. Nasal polyposis in churg-strauss syndrome. (0 replies)
  47. One year administration of anti-ige to a patient with churg-strauss syndrome (0 replies)
  48. Pathogenesis of pr3-anca associated vasculitis. (1 reply)
  49. Associations of churg-strauss syndrome with the hla-drb1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by vaglio et al (1 reply)
  50. Montelukast: churg-strauss syndrome: 3 case reports (1 reply)
  51. Pulmonary manifestations of the churg-strauss syndrome and related idiopathic small vessel vasculitis syndromes. (1 reply)
  52. Omalizumab: churg-strauss syndrome: case report. (1 reply)
  53. Omalizumab: churg-strauss syndrome: case report (1 reply)
  54. Intracerebral hemorrhage in a patient with churg-strauss syndrome (1 reply)
  55. Omalizumab: churg-strauss syndrome in a patient following a reduction in corticosteroid dosage?: case report (0 replies)
  56. Immunotherapies: churg-strauss syndrome: case report (0 replies)
  57. Omalizumab: churg-strauss syndrome in a patient following a reduction in corticosteroid dosage?: case report. (0 replies)
  58. [a patient with churg-strauss syndrome presenting as guillain-barré syndrome.] (0 replies)
  59. Immunotherapies: churg-strauss syndrome: case report. (0 replies)
  60. Hla-drb4 as a genetic risk factor for churg-strauss syndrome (1 reply)
  61. Pulmonary manifestations of the churg-strauss syndrome and related idiopathic small vessel vasculitis syndromes (1 reply)
  62. Potential target of infliximab in autoimmune and inflammatory diseases. (1 reply)
  63. Phrenic nerve palsy in a patient of churg strauss syndrome and mononeuritis multiplex (1 reply)
  64. Anca vasculitis: microscopic polyangiitis, wegener's granulomatosis, and churg-strauss syndrome. (1 reply)
  65. [papers] peripheral neuropathy in wegener's granulomatosis, churg strauss syndrome and microscopic polyangiitis (1 reply)
  66. Leukotriene receptor antagonists and churg-strauss syndrome: cause, trigger or merely an association? (1 reply)
  67. Leukotriene receptor antagonists and churg-strauss syndrome: cause, trigger or merely an association? (1 reply)
  68. Montelukast: churg-strauss syndrome: 3 case reports. (1 reply)
  69. Anca-associated vasculitis: diagnosis, clinical characteristics and treatment. (1 reply)
  70. Pulmonary eosinophilic syndromes. (1 reply)
  71. Clinical review: treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review (1 reply)
  72. Treatment of antineutrophil cytoplasmic antibody–associated vasculitis – systematic review (1 reply)
  73. Detection of myocardial inflammation by contrast-enhanced mri in a patient with churg-strauss syndrome. (1 reply)
  74. Indications for biotherapy in systemic vasculitides (1 reply)
  75. Small-vessel vasculitis: therapeutic management (1 reply)
  76. Central retinal artery occlusion in an anca negative churg-strauss syndrome patient (1 reply)
  77. Administration of anti-ige to a churg-strauss syndrome patient (1 reply)
  78. Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of churg-strauss syndrome (1 reply)
  79. Original contribution: skin denervation and cutaneous vasculitis in eosinophilia-associated neuropathy (1 reply)
  80. Prevalence of wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and churg strauss syndrome within a defined population in southern sweden (1 reply)
  81. Pulmonary manifestations of the churg-strauss syndrome and related idiopathic small vessel vasculitis syndromes. (1 reply)
  82. Churg-strauss syndrome triggered by hyposensitization to alternaria fungus (1 reply)
  83. [rsna education exhibits] eosinophilic lung diseases: a clinical, radiologic, and pathologic overview (1 reply)
  84. Neuropsychiatric disease in collagen vascular diseases and vasculitis (1 reply)
  85. Churg-strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients (1 reply)
  86. Eosinophilia: a study of 100 hospitalized patients. (1 reply)
  87. A case of budd-chiari syndrome presenting in a lady with newly diagnosed churg-strauss syndrome (1 reply)
  88. A case of budd-chiari syndrome presenting in a lady with newly diagnosed churg-strauss syndrome (1 reply)
  89. A case of budd-chiari syndrome presenting in a lady with newly diagnosed churg-strauss syndrome (1 reply)
  90. Topical steroids in the management of churg-strauss syndrome involving the conjunctiva. (1 reply)
  91. Small vessel vasculitis. (1 reply)
  92. Cutaneous vasculitis: diagnosis and management. (1 reply)
  93. Churg–strauss syndrome presenting with massive pericardial effusion (1 reply)
  94. Montelukast: churg-strauss syndrome: case report (1 reply)
  95. Montelukast: churg-strauss syndrome: case report. (1 reply)
  96. Mjm ward rounds 02/09/05 (1 reply)
  97. Increased expression of trail receptor 3 on eosinophils in churg-strauss syndrome (1 reply)
  98. Osler and the churg-strauss syndrome (1 reply)
  99. [extended reports] development and validation of a consensus methodology for the classification of the anca-associated vasculitides and polyarteritis nodosa for epidemiological studies (1 reply)
  100. See your message here (1 reply)
  101. [restrictive cardiomyopathy in a patient with the churg-strauss syndrome.] (1 reply)
  102. [letters] successful use of rituximab in a patient with recalcitrant churg-strauss syndrome (1 reply)
  103. Original paper antineutrophil cytoplasmic antibodies in patients with rheumatoid arthritis (1 reply)
  104. Churg-strauss syndrome (1 reply)
  105. Systemic vasculitis syndromes: churg-strauss syndrome (1 reply)
  106. Churg-strauss syndrome: the clinical features and long-term follow-up of 17 patients. (1 reply)
  107. Advances in the treatment of small vessel vasculitis. (1 reply)
  108. Elevated troponins and the churg-strauss syndrome: a case report (1 reply)
  109. Asthma drug use and the development of churg-strauss syndrome (css) (1 reply)
  110. Discoidin domain receptor 1 contributes to eosinophil survival in an nf-{kappa}b-dependent manner in churg-strauss syndrome (1 reply)
  111. Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a childhood arthritis and rheumatology alliance (carra) survey. (1 reply)
  112. Observation: wells syndrome in adults and children: a report of 19 cases (1 reply)
  113. Churg-strauss syndrome in children: a clinical and pathologic review (1 reply)
  114. Antineutrophil cytoplasmic antibodies. (1 reply)
  115. Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast. (1 reply)
  116. Outcome and prognostic factors during the course of primary small-vessel vasculitides. (1 reply)
  117. Cerebral venous thrombosis as a rare onset of churg-strauss syndrome. (1 reply)
  118. Discoidin domain receptor 1 contributes to eosinophil survival in an nf-{kappa}b-dependent ... (1 reply)
  119. Sponsorship Opportunity (1 reply)
  120. Churg-strauss syndrome. (1 reply)
  121. Sponsorship Opportunity (1 reply)
  122. Churg-strauss syndrome (1 reply)
  123. Original paper antineutrophil cytoplasmic antibodies in patients with rheumatoid arthritis (1 reply)
  124. [letters] successful use of rituximab in a patient with recalcitrant churg-strauss syndrome (1 reply)
  125. Outcome and prognostic factors during the course of primary small-vessel vasculitides. (1 reply)
  126. Cerebral venous thrombosis as a rare onset of churg-strauss syndrome. (1 reply)
  127. Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast. (1 reply)
  128. Antineutrophil cytoplasmic antibodies. (1 reply)
  129. Churg-strauss syndrome in children: a clinical and pathologic review (1 reply)
  130. Observation: wells syndrome in adults and children: a report of 19 cases (1 reply)
  131. Elevated troponins and the churg-strauss syndrome: a case report (1 reply)
  132. Advances in the treatment of small vessel vasculitis. (1 reply)
  133. Churg-strauss syndrome: the clinical features and long-term follow-up of 17 patients. (1 reply)
  134. Systemic vasculitis syndromes: churg-strauss syndrome (1 reply)
  135. Churg-strauss syndrome presenting as an abdominal mass in a non-asthmatic child. (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.